← All peptidesPDA-V1 attestation Citations
verifiedBioGate · GREENGrade B
Hexarelin
HwAWfKHexapeptide GH secretagogue; potent GHS-R1a agonist with cardioprotective signaling via CD36 in preclinical models.
D-Trp²D-Phe⁵amidated C-terminus
MW
887.00
Length
6aa
Posterior
29.6%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · D-Trp²
Cryptographic chain of custody.
- Outer PDA hash
- Inputs hash
- Merkle root
- TEE attestation
- Protocol version
- PDA-V1
- Source
- peptide-md
- Model version
- structure-fm-2026.04
- Candidates emitted
- 3
- Signed
- 2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with
@peptide-md/verifier.Real-world evidence
Cohort-attested outcomes.
Cohorts
6
Participants
293
Mean Δ
+4.31
Δ HRV ms (8-week) · 95% CI [3.65, 4.96]
IPNFT · Molecule IPNFT V2Solana
Hexarelin
b269f4…57b569Royalty cascade
8.84%
Holders
127
Royalty cascade routes lab fees, licensing, and OEA-attested cohort revenues back to holders, the cohort treasury, and the originating researchers in a 60 / 25 / 15 split.
Source literature.
Grade B1994 · Eur J Clin Pharmacol
Growth hormone-releasing activity of hexarelin in humans
Imbimbo BP et al.